Remalante-Rayco P, Baja ES, Baskurt Z, Chim T, Panelo CIA, Osio-Salido E, Inman RD, Dans LF, Haroon N. Impact of clinical subtype and sex on first-line biologic therapy discontinuation in axial spondyloarthritis. Ann Rheum Dis. 2025 Feb 6:S0003-4967(25)00052-4. (2025)
https://pubmed.ncbi.nlm.nih.gov/39919972/

Pacheco A, Maguire S, Qaiyum Z, Tang M, Bridger A, Lim M, Tavasolian F, Yau E, Crome SQ, Haroon N, Inman RD. Enhanced Type 1 Interferon Signature in Axial Spondyloarthritis Patients Unresponsive to Secukinumab Treatment. Arthritis Rheumatol. 2025 Jan;77(1):34-46. (2024)
https://pubmed.ncbi.nlm.nih.gov/39160761/

Brown MA, Rudwaleit M, van Gaalen FA, Haroon N, Gensler LS, Fleurinck C, Marten A, Massow U, de Peyrecave N, Vaux T, White K, Deodhar A, van der Horst-Bruinsma I. Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials. Ann Rheum Dis. 2024 Nov 14;83(12):1722-1730. (2024)
https://pubmed.ncbi.nlm.nih.gov/38977276/

Gendron E, Maguire S, Anderson M, Johnson SR, Inman RD, Haroon N. The effect of alcohol consumption on clinical outcomes and structural damage in patients with axial spondyloarthritis: A systematic literature review and meta-analysis. Joint Bone Spine. 2025 Jan;92(1):105794 (2024)
https://pubmed.ncbi.nlm.nih.gov/39461411/

Advances in axial spondyloarthritis: Learning from the leaders (2023)
https://pubmed-ncbi-nlm-nih-gov.myaccess.library.utoronto.ca/37985319/

Incidence and predictors of demyelinating disease in spondyloarthritis: data from a longitudinal cohort study (2023)
https://pubmed-ncbi-nlm-nih-gov.myaccess.library.utoronto.ca/37792508/

Prostaglandin E2/EP4 axis is upregulated in Spondyloarthritis and contributes to radiographic progression (2023)
https://pubmed-ncbi-nlm-nih-gov.myaccess.library.utoronto.ca/37075950/

Determination of Relative Weightings for Sacroiliac Joint Pathologies in the OMERACT Juvenile Arthritis Magnetic Resonance Imaging Sacroiliac Joint Score (2023)
https://pubmed-ncbi-nlm-nih-gov.myaccess.library.utoronto.ca/37048812/

ERAP1 and the return of the UPR in ankylosing spondylitis (2023)
https://pubmed-ncbi-nlm-nih-gov.myaccess.library.utoronto.ca/36725927/

Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials (2023)
https://pubmed.ncbi.nlm.nih.gov/36649967/

Work-Related Issues and Physical and Psychological Burden in Canadian Patients With Axial Spondyloarthritis: Results From the International Map of Axial Spondyloarthritis (2023)
https://pubmed.ncbi.nlm.nih.gov/36455954/

Isolated axial disease in psoriatic arthritis and ankylosing spondylitis with psoriasis (2023)
https://pubmed.ncbi.nlm.nih.gov/35973805/

Motivators, Barriers, and Opportunity for E-Health to Encourage Physical Activity in Axial Spondyloarthritis: A Qualitative Descriptive Study (2022)
https://pubmed.ncbi.nlm.nih.gov/34928533/

Nonspecific Low Back Pain (2022)
https://pubmed.ncbi.nlm.nih.gov/35921469/

Minimal Impact of the COVID-19 Pandemic on Disease Activity and Health-Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2b Open-Label Extension Study (2022)
https://pubmed.ncbi.nlm.nih.gov/35833532/

Instrument selection for the ASAS core outcome set for axial spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35680390/

Tender to touch-Prevalence and impact of concomitant fibromyalgia and enthesitis in spondyloarthritis: An ancillary analysis of the ASAS PerSpA study (2022)
https://pubmed.ncbi.nlm.nih.gov/35636706/

COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to Controls (2022)
https://pubmed.ncbi.nlm.nih.gov/35105713/

Motivators, Barriers, and Opportunity for E-Health to Encourage Physical Activity in Axial Spondyloarthritis: A Qualitative Descriptive Study (2022)
https://pubmed.ncbi.nlm.nih.gov/34928533/

Complexity of enthesitis and new bone formation in ankylosing spondylitis: current understanding of the immunopathology and therapeutic approaches (2022)
https://pubmed.ncbi.nlm.nih.gov/34918137/

Understanding COVID-19 Risk in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Analysis of SARS-CoV-2 Testing (2022)
https://pubmed.ncbi.nlm.nih.gov/34486829/

Understanding COVID-19 Risk in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Analysis of SARS-CoV-2 Testing (2022)
https://pubmed.ncbi.nlm.nih.gov/34486829/

Bridging the Gap Between Symptom Onset and Diagnosis in Axial Spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/34268914/

Macrophage migration inhibitory factor drives pathology in a mouse model of spondyloarthritis and is associated with human disease (2021)
https://pubmed.ncbi.nlm.nih.gov/34669443/

The ASAS-OMERACT core domain set for axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34489113/

The gut-enthesis axis and the pathogenesis of Spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/35850909/

Macrophage migration inhibitory factor drives pathology in a mouse model of spondyloarthritis and is associated with human disease (2021)
https://pubmed.ncbi.nlm.nih.gov/34669443/

Reliability of the Preliminary OMERACT Juvenile Idiopathic Arthritis MRI Score (OMERACT JAMRIS-SIJ) (2021)
https://pubmed.ncbi.nlm.nih.gov/34640579/

The ASAS-OMERACT core domain set for axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34489113/

Recent Updates in the Immunopathology of Type 3 Immunity-Mediated Enthesitis (2021)
https://pubmed.ncbi.nlm.nih.gov/33893896/

Recent advances in spondyloarthritis: positive developments in the seronegative domain (2021)
https://pubmed.ncbi.nlm.nih.gov/33763750/

Aberrant antigen processing and presentation: Key pathogenic factors leading to immune activation in Ankylosing spondylitis (2021)
https://pubmed.ncbi.nlm.nih.gov/33774593/

Aberrant antigen processing and presentation: Key pathogenic factors leading to immune activation in Ankylosing spondylitis (2021)
https://pubmed.ncbi.nlm.nih.gov/33532928/

COVID-19: What Do Rheumatologists Need to Know? (2021)
https://pubmed.ncbi.nlm.nih.gov/33403528/

Acute mental health service use is increased in rheumatoid arthritis and ankylosing spondylitis: a population-based cohort study (2020)
https://pubmed.ncbi.nlm.nih.gov/32550868/

The risk of deliberate self-harm following a diagnosis of rheumatoid arthritis or ankylosing spondylitis: A population-based cohort study (2020)
https://pubmed.ncbi.nlm.nih.gov/32084192/

Effect of TNF-inhibitor therapy on spinal structural progression in ankylosing spondylitis patients: A systematic review and meta-analysis (2020)
https://pubmed-ncbi-nlm-nih-gov.myaccess.library.utoronto.ca/32419337/

Patient-reported Disease Activity in an Axial Spondyloarthritis Cohort during the COVID-19 Pandemic (2020)
https://pubmed.ncbi.nlm.nih.gov/32893508/

Acute mental health service use is increased in rheumatoid arthritis and ankylosing spondylitis: a population-based cohort study (2020)
https://pubmed.ncbi.nlm.nih.gov/32550868/

Effect of TNF-inhibitor therapy on spinal structural progression in ankylosing spondylitis patients: A systematic review and meta-analysis (2020)
https://pubmed.ncbi.nlm.nih.gov/32419337/

Effect of TNF-inhibitor therapy on spinal structural progression in ankylosing spondylitis patients: A systematic review and meta-analysis (2020)
https://pubmed.ncbi.nlm.nih.gov/32419337/